The pathophysiology of diarrhea associated with Zepbound relates to its dual incretin receptor agonist mechanism
[1] [7] This dual-receptor agonist represents a significant advancement in metabolic therapeutics, offering enhanced glycemic control and weight reduction compared to single-receptor GLP-1 agonists
Potential Benefits Works through amylin receptors rather than GLP-1, offering an alternative pathway for patients who may not respond optimally to GLP-1 medications alone
"The classic framework is that if you only have one, it comes down from the list price to 75 per cent," Tadrous said
In the future, it is recommended to include a more significant number of follow-up studies based on unified criteria to understand better the relationship between obesity and psychiatric disorders, including suicide, anxiety and depression [36, 37]
Critically, Direct Meds does not practice medicine and does not make prescribing decisions